Mode
Text Size
Log in / Sign up

How do MicroRNAs affect the biology of my melanoma cells?

moderate confidence  ·  Last reviewed May 13, 2026

MicroRNAs (miRNAs) are tiny pieces of RNA that do not code for proteins but instead help control which genes are turned on or off in your cells. In melanoma, these miRNAs can act like 'brakes' or 'gas pedals' for cancer growth. Some miRNAs stop melanoma cells from multiplying or spreading, while others help the cancer grow, invade nearby tissue, and resist treatment. They also affect how your immune system responds to the tumor. Understanding which miRNAs are active in your melanoma may help doctors predict how aggressive the cancer is and whether certain treatments might work better for you.

What the research says

MicroRNAs play multiple roles in melanoma biology. They can act as tumor suppressors (slowing cancer) or oncogenes (promoting cancer) by targeting specific genes involved in cell growth, survival, and movement 410. For example, certain miRNAs are involved in every step of metastasis — the process where melanoma cells break away, travel through blood or lymph, and form new tumors in other parts of the body 10. They also help create a 'pre-metastatic niche' in distant organs, making those sites more welcoming for arriving cancer cells 10.

Beyond the cancer cells themselves, miRNAs regulate the tumor immune microenvironment. They influence how immune cells are recruited and how they function, and they can affect immune checkpoint molecules that tumors use to hide from the immune system 4. This means miRNAs can impact whether your body's immune defenses recognize and attack the melanoma.

MicroRNAs are also carried in tiny particles called extracellular vesicles (EVs) that are released by melanoma cells. These EVs can transfer miRNAs to nearby cells or to cells in distant parts of the body, spreading signals that promote tumor growth, new blood vessel formation (angiogenesis), and drug resistance 9. Because miRNAs can be detected in blood samples (liquid biopsies), they are being studied as potential biomarkers for early detection of melanoma and for monitoring how well treatment is working 10.

What to ask your doctor

  • Could testing for specific microRNAs in my tumor or blood help predict how aggressive my melanoma is?
  • Are there any clinical trials looking at microRNA-based treatments for melanoma?
  • How might the microRNA profile of my melanoma affect my response to immunotherapy or targeted therapy?
  • Should I consider having my tumor's microRNA expression analyzed as part of my treatment planning?
  • What is known about the role of microRNAs in melanoma recurrence or metastasis in my specific case?

This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.